Journal: bioRxiv
Article Title: Unilateral loss of tyrosine hydroxylase in adult midbrain dopaminergic neurons reveals reduction to neuregulin1 in rat model of acute dopaminergic dysfunction
doi: 10.64898/2026.10.09.757761
Figure Lengend Snippet: (A) Mean responses are shown for both the Rosa26 gRNA (black) and Th gRNA (red) hemisphere. Individual recordings are shown in light gray. (B) Mean response for the control recordings is scaled to the peak amplitude of the mean Th gRNA response. Note the decay of the Rosa26 gRNA response is slightly prolonged, relative to the Th gRNA response. (C) Effect of 4-AP (30 µM) on the DA signal. Inset shows the baseline response scaled to the peak amplitude of the 4-AP response. (D) DA release under baseline conditions (gray) and in the presence of 4-AP (orange). Under both baseline conditions and in the presence of 4-AP, release did not significantly differ between control and Th gRNA (two way RM-ANOVA, F 1,36 = 3.44, p =0.07; Baseline control vs. baseline TH-, p = 0.68; 4-AP control vs. 4-AP TH-, p = 0.08, Sidak post-hoc). 4-AP significantly increased DA release in both Rosa26 and Th gRNA (two way RM-ANOVA, F 1,36 = 74.05, p <0.001; ***p <0.001, Th gRNA baseline vs. Th gRNA 4-AP; Rosa26 baseline vs. Rosa26 4-AP, Sidak-post hoc). (E) DA uptake summary: Under baseline conditions, uptake was slightly but significantly increased in Th gRNA slices, relative to control slices (two way RM-ANOVA, F 1,36 = 5.64, p =0.02; *p=0.04, baseline Rosa26 gRNA vs. baseline Th gRNA, Sidak post-hoc). This increase was absent following 4-AP treatment (4-AP Rosa26 gRNA vs. 4-AP Th gRNA, p =0.30, Sidak post-hoc). Note that 4-AP significantly decreased uptake in both Rosa26 gRNA and Th gRNA slices (two way RM-ANOVA, F 1,36 = 76.18, p <0.001; ***p< 0.001, Rosa26 gRNA baseline vs. Rosa26 gRNA 4-AP; Th gRNA baseline vs. Th gRNA 4AP, Sidak post-hoc). (F-I) HPLC measuring dopamine and dopamine metabolites from Dat-iCre x Cas9 brain punches two weeks post gRNA injection. (F) DA concentration (ng/g) from midbrain punches (paired t test, t = 9.35, df = 4, ***p = 0.0007). (G) DA concentration (ng/g) from striatal punches (paired t test, t = 0.07, df = 4, p = 0.95). (H) DOPAC concentration (ng/g) from striatal punches (paired t test, t = 0.55, df = 4, p = 0.61). (I) HVA concentration (ng/g) from striatal punches (paired t test, t = 0.55, df = 4, p = 0.61).
Article Snippet: Animals were injected with pAAV Rosa26 gRNA A+B EF1a EGFP (Addgene 113156) and pAAV TH gRNA A+B pair EF1a EGFP (Addgene 113155) previously described in Bӓck et al 2019 at a viral titer of 1.95e12 viral genomes/mL.
Techniques: Control, Injection, Concentration Assay